A Reduced Pancreatic Polypeptide Response is Associated With New-onset Pancreatogenic Diabetes Versus Type 2 Diabetes.
Saved in:
| Title: | A Reduced Pancreatic Polypeptide Response is Associated With New-onset Pancreatogenic Diabetes Versus Type 2 Diabetes. |
|---|---|
| Authors: | Hart PA; Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA., Kudva YC; Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA., Yadav D; Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA., Andersen DK; Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20814, USA., Li Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Toledo FGS; Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA., Wang F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Bellin MD; Departments of Pediatrics and Surgery, University of Minnesota Medical School, Minneapolis, MN 55455, USA., Bradley D; Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA., Brand RE; Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA., Cusi K; Division of Endocrinology & Metabolism, University of Florida, Gainesville, FL 32611, USA., Fisher W; Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA., Mather K; Division of Endocrinology, Indiana University School of Medicine, Indianapolis, IN 46202, USA., Park WG; Division of Gastroenterology & Hepatology, Stanford University School of Medicine, Stanford, CA 94305, USA., Saeed Z; Division of Endocrinology, Indiana University School of Medicine, Indianapolis, IN 46202, USA., Considine RV; Division of Endocrinology, Indiana University School of Medicine, Indianapolis, IN 46202, USA., Graham SC; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Rinaudo JA; Cancer Biomarker Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA., Serrano J; Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20814, USA., Goodarzi MO; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. |
| Source: | The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2023 Apr 13; Vol. 108 (5), pp. e120-e128. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
